{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:22:17Z","timestamp":1715988137356},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1998,4,1]],"date-time":"1998-04-01T00:00:00Z","timestamp":891388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[1998,4]]},"DOI":"10.1016\/s0166-3542(98)00004-7","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T04:29:52Z","timestamp":1027657792000},"page":"63-73","source":"Crossref","is-referenced-by-count":6,"title":["Synergistic inhibition of HIV-1 by an antisense oligonucleotide and nucleoside analog reverse transcriptase inhibitors"],"prefix":"10.1016","volume":"38","author":[{"given":"Gareth J","family":"Veal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudhir","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randal A","family":"Byrn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0166-3542(98)00004-7_BIB1","doi-asserted-by":"crossref","unstructured":"Agrawal, S., Goodchild, J., Civeira, M.P., Thornton, A.H., Sarin, P.S., Zamecnik, P.C., 1988. Oligodeoxynucleoside phosphoramidates and phosphorothioates as inhibitors of human immunodeficiency virus (published erratum appears in Proc Natl Acad Sci USA 1989 Mar 86(5):1504). Proc. Nat. Acad. Sci. USA 85, 7079\u20137083.","DOI":"10.1073\/pnas.85.19.7079"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/ard.1992.2.261","article-title":"GEM 91: an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS (editorial)","volume":"2","author":"Agrawal","year":"1992","journal-title":"Antisense Res. Dev."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0006-2952(88)90178-5","article-title":"The in vitro and in vivo anti-retrovirus activity and intracellular metabolism of 3\u2032-azido-2\u2032,3\u2032-dideoxythymidine and 2\u2032,3\u2032-dideoxycytidine are highly dependent on the cell species","volume":"37","author":"Balzarini","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB4","first-page":"328","article-title":"Cytostatic effects of 2\u2032,3\u2032-dideoxyribonucleosides on transformed human hemopoietic cell lines","volume":"37","author":"Blackley","year":"1990","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB5","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.92.20.9383","article-title":"Sequence-specific inhibition of HIV reverse transcription by antisense oligonucleotides-comparative study in cell-free assays and in HIV-infected cells","volume":"92","author":"Bordier","year":"1995","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB6","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1073\/pnas.92.9.4051","article-title":"The anti-proliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a non-antisense mechanism","volume":"92","author":"Burgess","year":"1995","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1089\/aid.1991.7.943","article-title":"Differential alteration of the anti-HIV-1 effect of phosphorothioate oligonucleotide S-dC28 by AZT, interferon-\u03b1 and dextran sulfate","volume":"7","author":"Chou","year":"1991","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Advances Enzyme Regulation"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB9","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/AAC.41.4.875","article-title":"Effects of RP 55\u2008778, a tumor necrosis factor alpha synthesis inhibitor, on antiviral activity of dideoxynucleosides","volume":"41","author":"Clayette","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM199604183341602","article-title":"Treatment of human immunodeficiency virus infection with saquinavir, zidovudine and zalcitabine. AIDS Clinical Trials Group","volume":"334","author":"Collier","year":"1996","journal-title":"New Engl. J. Med."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB11","doi-asserted-by":"crossref","unstructured":"Delta Co-ordinating Committee, 1996. Delta: A randomised double-blind controlled trial comparing combinations of zidovudine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet 348, 283\u2013291.","DOI":"10.1016\/S0140-6736(96)05387-1"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB12","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1128\/AAC.40.6.1346","article-title":"Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication","volume":"40","author":"Deminie","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB13","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.1016\/S0021-9258(18)99923-0","article-title":"Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2\u2032,3\u2032-dideoxynucleoside analogs in resting and activated human cells","volume":"269","author":"Gao","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB14","first-page":"767","article-title":"Anti-human immunodeficiency virus type 1 activity of hydroxyurea in combination with 2\u2032,3\u2032-dideoxynucleosides","volume":"46","author":"Gao","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB15","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1172\/JCI116463","article-title":"Differential phosphorylation of azidothymidine, dideoxycytidine and dideoxyinosine in resting and activated peripheral blood mononuclear cells","volume":"91","author":"Gao","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB16","first-page":"3","article-title":"What we know so far","volume":"10","author":"Gazzard","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00042560-199510001-00014","article-title":"Combination therapy from a clinician\u2019s perspective","volume":"10","author":"Goebel","year":"1995","journal-title":"J. Acquired Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB18","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJM199610103351501","article-title":"A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team","volume":"335","author":"Hammer","year":"1996","journal-title":"New Engl. J. Med."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00042560-199510001-00010","article-title":"Current HIV clinical trial design issues","volume":"10","author":"Lange","year":"1995","journal-title":"J. Acquired Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB21","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1097\/00042560-199510001-00016","article-title":"Triple combinations: present and future","volume":"10","author":"Lange","year":"1995","journal-title":"J. Acquired Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB22","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1073\/pnas.91.17.7942","article-title":"Antisense oligodeoxynucleotide phosphorothioate complementary to gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells","volume":"91","author":"Lisziewicz","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB23","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1073\/pnas.84.21.7706","article-title":"Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus","volume":"84","author":"Matsukura","year":"1987","journal-title":"Proc. Nat. Acad. Sci. USA"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0166-0934(88)90134-6","article-title":"Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds","volume":"20","author":"Pauwels","year":"1988","journal-title":"J. Virol. Methods"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB26","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1182\/blood.V80.4.995.995","article-title":"Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte\/macrophages","volume":"80","author":"Perno","year":"1992","journal-title":"Blood"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB27","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.6200935","article-title":"Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS","volume":"224","author":"Popovic","year":"1984","journal-title":"Science"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB28","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1128\/AAC.39.11.2555","article-title":"Comparative analysis of anti-human immunodeficiency virus type 1 activities of dideoxynucleoside analogs in resting and activated peripheral blood mononuclear cells","volume":"39","author":"Shirasaka","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/clinids\/16.Supplement_1.S7","article-title":"Nucleoside analogs: similarities and differences","volume":"16","author":"Sommadossi","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB30","doi-asserted-by":"crossref","unstructured":"St. Clair, M., Pennington, K.N., Rooney, J., Barry, D.W., 1995. Rapid screening of antiviral combinations. J. Acquired Immune Defic. Syndr. Hum. Retrovirol 10 (S1), S24\u2013S27.","DOI":"10.1097\/00042560-199510001-00006"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB31","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.2435003","article-title":"Ribavirin antagonizes the effect of azidothymidine on HIV replication","volume":"235","author":"Vogt","year":"1987","journal-title":"Science"},{"key":"10.1016\/S0166-3542(98)00004-7_BIB32","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/infdis\/157.5.1047","article-title":"Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus","volume":"157","author":"Vujcic","year":"1988","journal-title":"J. Infect. Dis."},{"key":"10.1016\/S0166-3542(98)00004-7_BIB33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/aid.1997.13.545","article-title":"The multiple inhibitory mechanisms of GEM91, a gag antisense phosphorothioate oligonucleotide, for human immunodeficiency virus type-1","volume":"13","author":"Yamaguchi","year":"1997","journal-title":"AIDS Res. Hum. Retrovir."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354298000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354298000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T03:16:07Z","timestamp":1621048567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354298000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,4]]}},"alternative-id":["S0166354298000047"],"URL":"https:\/\/doi.org\/10.1016\/s0166-3542(98)00004-7","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[1998,4]]}}}